• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌诊断患者的体验:定性证据的系统评价

The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence.

作者信息

Edmondson Amanda J, Birtwistle Jacqueline C, Catto James W F, Twiddy Maureen

机构信息

Centre for Applied Research in Health, University of Huddersfield, Huddersfield, UK.

Institute of Health Sciences, University of Leeds, Leeds, UK.

出版信息

J Cancer Surviv. 2017 Aug;11(4):453-461. doi: 10.1007/s11764-017-0603-6. Epub 2017 Feb 17.

DOI:10.1007/s11764-017-0603-6
PMID:28213769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5500680/
Abstract

PURPOSE

Bladder cancer (BC) is a common disease with disparate treatment options and variable outcomes. Despite the disease's high prevalence, little is known of the lived experience of affected patients. National patient experience surveys suggest that those with BC have poorer experiences than those with other common cancers. The aim of this review is to identify first-hand accounts of the lived experiences of diagnosis through to survivorship.

METHOD

This is a systematic review of the qualitative evidence reporting first-hand accounts of the experiences of being diagnosed with, treated for and surviving bladder cancer. A thematic analysis and 'best-fit' framework synthesis was undertaken to classify these experiences.

RESULTS

The inconsistent nature of symptoms contributes to delays in diagnosis. Post-diagnosis, many patients are not actively engaged in the treatment decision-making process and rely on their doctor's expertise. This can result in patients not adequately exploring the consequences of these decisions. Learning how to cope with a 'post-surgery body', changing sexuality and incontinence are distressing. Much less is known about the quality of life of patients receiving conservative treatments such as Bacillus Calmette-Guerin (BCG).

CONCLUSIONS

The review contributes to a greater understanding of the lived experience of bladder cancer. Findings reflect a paucity of relevant literature and a need to develop more sensitive patient-reported outcome measures (PROMs) and incorporate patient-reported outcomes in BC care pathways.

IMPLICATIONS FOR CANCER SURVIVORS

Collective knowledge of the patients' self-reported experience of the cancer care pathway will facilitate understanding of the outcomes following treatment.

摘要

目的

膀胱癌(BC)是一种常见疾病,治疗选择各异,预后也不尽相同。尽管该疾病发病率很高,但对于受影响患者的生活经历却知之甚少。全国患者体验调查表明,膀胱癌患者的体验比其他常见癌症患者更差。本综述的目的是确定从诊断到 survivorship 的生活经历的第一手描述。

方法

这是一项对定性证据的系统综述,报告了被诊断为膀胱癌、接受治疗并存活下来的患者的第一手经历。采用主题分析和“最佳拟合”框架综合法对这些经历进行分类。

结果

症状的不一致性导致诊断延迟。诊断后,许多患者没有积极参与治疗决策过程,而是依赖医生的专业知识。这可能导致患者没有充分探讨这些决策的后果。学习如何应对“手术后的身体”、性方面的变化和尿失禁令人痛苦。对于接受诸如卡介苗(BCG)等保守治疗的患者的生活质量了解得更少。

结论

该综述有助于更深入地了解膀胱癌患者的生活经历。研究结果反映出相关文献匮乏,需要开发更敏感的患者报告结局测量指标(PROMs),并将患者报告的结局纳入膀胱癌护理路径。

对癌症幸存者的启示

患者对癌症护理路径的自我报告经历的集体知识将有助于理解治疗后的结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/975d/5500680/7494bbcbaeb3/11764_2017_603_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/975d/5500680/7494bbcbaeb3/11764_2017_603_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/975d/5500680/7494bbcbaeb3/11764_2017_603_Fig1_HTML.jpg

相似文献

1
The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence.膀胱癌诊断患者的体验:定性证据的系统评价
J Cancer Surviv. 2017 Aug;11(4):453-461. doi: 10.1007/s11764-017-0603-6. Epub 2017 Feb 17.
2
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
3
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Experiences of gynecological cancer patients receiving care from specialist nurses: a qualitative systematic review.妇科癌症患者接受专科护士护理的体验:一项定性系统综述。
JBI Database System Rev Implement Rep. 2017 Aug;15(8):2087-2112. doi: 10.11124/JBISRIR-2016-003126.
6
Community views on mass drug administration for soil-transmitted helminths: a qualitative evidence synthesis.社区对土壤传播蠕虫群体药物给药的看法:定性证据综合分析
Cochrane Database Syst Rev. 2025 Jun 20;6:CD015794. doi: 10.1002/14651858.CD015794.pub2.
7
A qualitative interview study exploring patients' views and experiences of treatment for hidradenitis suppurativa in the UK.一项定性访谈研究,探讨英国化脓性汗腺炎患者对治疗的看法和经历。
Br J Dermatol. 2025 Jun 20;193(1):85-92. doi: 10.1093/bjd/ljaf046.
8
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.
9
Exercise interventions and patient beliefs for people with hip, knee or hip and knee osteoarthritis: a mixed methods review.髋、膝或髋膝骨关节炎患者的运动干预和患者信念:一项混合方法综述
Cochrane Database Syst Rev. 2018 Apr 17;4(4):CD010842. doi: 10.1002/14651858.CD010842.pub2.
10
Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews.保守干预治疗女性尿失禁:Cochrane 系统综述概述。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD012337. doi: 10.1002/14651858.CD012337.pub2.

引用本文的文献

1
Development and evaluation of a quality-of-life questionnaire for patients with orbital malignant tumours.眼眶恶性肿瘤患者生活质量问卷的研制与评价
BMJ Open Ophthalmol. 2025 Jun 26;10(1):e001842. doi: 10.1136/bmjophth-2024-001842.
2
National audit of patient reported experience of radical cystectomy for bladder cancer pathways.膀胱癌根治性膀胱切除术患者报告体验的全国性审计。
BJUI Compass. 2024 Aug 19;5(10):961-968. doi: 10.1002/bco2.422. eCollection 2024 Oct.
3
Patient-centered development of a bladder cancer survivorship care plan.

本文引用的文献

1
Systematic review and qualitative evidence synthesis of patient-reported outcome measures for abdominal aortic aneurysm.系统评价和患者报告的腹主动脉瘤结局测量的定性证据综合。
Br J Surg. 2017 Mar;104(4):317-327. doi: 10.1002/bjs.10407. Epub 2016 Dec 9.
2
Treatment Decision Making in Patients with Bladder Cancer.膀胱癌患者的治疗决策制定
Bladder Cancer. 2015 Oct 26;1(2):151-158. doi: 10.3233/BLC-150029.
3
Quality of Life after Bladder Cancer: A Prospective Study Comparing Patient-related Outcomes after Radical Surgery or Radical Radiotherapy for Bladder Cancer.
以患者为中心制定膀胱癌生存护理计划。
Support Care Cancer. 2024 May 31;32(6):397. doi: 10.1007/s00520-024-08588-y.
4
Bladder Cancer Survivors Who Do Not Smoke Have Better Longitudinal Health-Related Quality of Life Measures: An Assessment of the Comparative Effectiveness and Survivorship Health in Bladder Cancer (CEASE-BC) Study.不吸烟的膀胱癌幸存者具有更好的纵向健康相关生活质量衡量指标:膀胱癌比较有效性和生存健康评估(CEASE-BC)研究。
J Urol. 2024 Jul;212(1):87-94. doi: 10.1097/JU.0000000000003964. Epub 2024 Apr 11.
5
Patient experience of bladder cancer: A data linkage study.膀胱癌患者体验:一项数据关联研究。
BJUI Compass. 2024 Jan 31;5(3):382-388. doi: 10.1002/bco2.325. eCollection 2024 Mar.
6
Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs.中高危非肌层浸润性膀胱癌:流行病学、疾病负担及未满足需求概述
Front Oncol. 2023 Jun 2;13:1170124. doi: 10.3389/fonc.2023.1170124. eCollection 2023.
7
Patient and Caregiver Perceptions of Advanced Bladder Cancer Systemic Treatments: Infodemiology Study Based on Social Media Data.患者及照护者对晚期膀胱癌全身治疗的认知:基于社交媒体数据的信息流行病学研究
JMIR Cancer. 2023 Mar 27;9:e45011. doi: 10.2196/45011.
8
Patient Preferences for Treatment of Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: A Cross-country Choice Experiment.卡介苗无反应性非肌层浸润性膀胱癌患者的治疗偏好:一项跨国选择实验
Eur Urol Open Sci. 2023 Jan 31;49:92-99. doi: 10.1016/j.euros.2022.12.016. eCollection 2023 Mar.
9
Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.验证和可靠性的荷兰版本的 EORTC QLQ-BLM30 模块评估健康相关的生活质量的患者肌肉浸润性膀胱癌。
Health Qual Life Outcomes. 2022 Dec 29;20(1):171. doi: 10.1186/s12955-022-02064-z.
10
Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer-a systematic review.非肌层浸润性膀胱癌患者监测期间的生活质量——一项系统评价
Transl Androl Urol. 2021 Jun;10(6):2737-2749. doi: 10.21037/tau-20-1333.
膀胱癌后的生活质量:一项前瞻性研究,比较膀胱癌根治性手术或根治性放疗后的患者相关结局。
Clin Oncol (R Coll Radiol). 2016 Jun;28(6):373-5. doi: 10.1016/j.clon.2015.12.002. Epub 2015 Dec 30.
4
Late effects of cancer and cancer treatment--the perspective of the patient.癌症及癌症治疗的晚期效应——患者视角
Support Care Cancer. 2016 Jan;24(1):337-346. doi: 10.1007/s00520-015-2796-4. Epub 2015 Jun 13.
5
Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer.膀胱癌:非肌层浸润性膀胱癌患者的生活质量
Nat Rev Urol. 2015 Apr;12(4):186-8. doi: 10.1038/nrurol.2015.12. Epub 2015 Feb 3.
6
Examining sexual dysfunction in non-muscle-invasive bladder cancer: results of cross-sectional mixed-methods research.检查非肌肉浸润性膀胱癌中的性功能障碍:横断面混合方法研究的结果。
Sex Med. 2014 Aug;2(3):141-51. doi: 10.1002/sm2.24.
7
Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion.膀胱切除术后与健康相关的生活质量(HRQoL):原位新膀胱与回肠膀胱术之间的比较。
Eur J Surg Oncol. 2015 Mar;41(3):295-9. doi: 10.1016/j.ejso.2014.05.006. Epub 2014 May 24.
8
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit.根治性膀胱切除术和回肠导管术后幸存者的行为特征和人类适应性。
Health Qual Life Outcomes. 2014 Apr 7;12:46. doi: 10.1186/1477-7525-12-46.
9
Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer.欧洲癌症研究与治疗组织(EORTC)QLQ-NMIBC24问卷模块用于评估非肌层浸润性膀胱癌患者报告结局的效度和信度测试。
Eur Urol. 2014 Dec;66(6):1148-56. doi: 10.1016/j.eururo.2014.02.034. Epub 2014 Feb 25.
10
The economics of bladder cancer: costs and considerations of caring for this disease.膀胱癌的经济学:治疗这种疾病的成本和考虑因素。
Eur Urol. 2014 Aug;66(2):253-62. doi: 10.1016/j.eururo.2014.01.006. Epub 2014 Jan 21.